VIVA (Vascular InterVentional Advances) 2021

VIVA (Vascular InterVentional Advances) 2021 is organized by VIVA Physicians and will be held from Oct 04 - 07, 2021 at Wynn Las Vegas. 

Target Audience:
VIVA is designed for physicians specializing in interventional cardiology; interventional and neurologic radiology; vascular medicine; vascular, neurologic, and cardiothoracic surgery; podiatry; fellows and residents; and allied health professionals (including nurses, vascular clinic staff, endovascular operating room staff, cath lab and angiography suite staff, nurse practitioners, vascular technologists, and physician assistants).

Accreditation:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University at Buffalo Jacobs School of Medicine and Biomedical Sciences and VIVA Physicians. The University at Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by the ACCME to provide continuing medical education for physicians.

The University at Buffalo Jacobs School of Medicine and Biomedical Sciences designates this live activity for a maximum of 21.3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CME credits are available for sessions attended live, either in person or virtually. Participants may not claim CME credit for watching recorded sessions after the live broadcast.

Description:
Now in its 19th year, VIVA continues to offer unparalleled endovascular education with a curriculum designed to engage practitioners across a variety of specialties. We are thrilled to return to Wynn Las Vegas once again to bring together our celebrated faculty of leading clinicians and researchers in interventional cardiology, interventional radiology, vascular medicine, and vascular surgery with the shared goal to present an impactful, transformative series of educational sessions.

VIVA21 will explore new and evolving therapies, best practices, and ongoing controversies to enhance your clinical perspective. Each session features multidisciplinary panels selected to foster a lively, interactive learning environment and provide a balanced look at the current state and future of endovascular care. In 2021 we are pleased to present:
• Great Debates, offering competing views from expert clinicians
• Groundbreaking research and trial data in the Late-Breaking Clinical Trials and Drinks and Data sessions
• International live cases from the U.S. and Germany
• Pre-courses focused on critical limb-threatening ischemia and aortic intervention
• Innovation sessions exploring tech development and the digitization of healthcare

Learning Objectives:
At the conclusion of the course, the targeted learners should be able to:
• Understand the current indications, risks, complications, and outcomes for hemodialysis vascular access as well as medical, interventional, and surgical therapies for peripheral arterial and venous diseases. • Incorporate advanced medical, endovascular, and surgical techniques and approaches into their own practices to improve the care and outcomes of patients.
• Implement high-quality guidelines-based programs to improve the early identification and care of patients with non-cardiac vascular conditions.
• Increase knowledge in critical decision-making and the comprehensive spectrum of care for patients with stroke, intracranial and extracranial carotid, and artery disease.
• Improve the delivery of balanced and scientifically valid vascular care in accordance with expert opinion and practice.
• Apply a strategic multidisciplinary and team-based approach to the treatment of vascular disease.
• Gain and then disseminate the most current knowledge base regarding vascular care as learned from experts in the field, exposure to live cases, and data from late-breaking clinical trials.